DocSym
β
Searchsearch
Search
(Z08.7) Follow-up examination after combined treatment for malignant neoplasm
More details coming soon
887 941 in individuals diagnosis follow-up examination after combined treatment for malignant neoplasm confirmed
Diagnosis follow-up examination after combined treatment for malignant neoplasm is diagnosed Men are 35.35% more likely than Women
600 929
Men receive the diagnosis follow-up examination after combined treatment for malignant neoplasm
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
287 012
Women receive the diagnosis follow-up examination after combined treatment for malignant neoplasm
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease follow-up examination after combined treatment for malignant neoplasm - Men and Women aged 65-69
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any ageLess common in women the disease occurs at Age 95+
In Women diagnosis is most often set at age 0-94
Disease Features follow-up examination after combined treatment for malignant neoplasm
Absence or low individual and public risk
Follow-up examination after combined treatment for malignant neoplasm - what does this mean
Follow-up examinations after combined treatment for malignant neoplasms are typically done to assess the effectiveness of the treatment. this may involve imaging studies such as x-rays, ct scans, or mris to check for any remaining cancer cells or to monitor for any recurrences. blood tests may also be done to check for any changes in tumor markers or other indicators of disease progression. additionally, physical examinations may be done to assess the patient's overall health status.
What happens during the disease - follow-up examination after combined treatment for malignant neoplasm
The pathogenesis of follow-up examination after combined treatment for malignant neoplasm is to monitor the patient for recurrence of the cancer, as well as any side effects from the treatments. the goal is to detect any recurrence of the cancer as early as possible, while minimizing the risk of side effects from the treatments. follow-up examinations may include imaging tests, laboratory tests, physical exams, and other tests to monitor the patient and detect any recurrence of the cancer.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Imaging tests (X-ray, CT scan, MRI, PET scan)
- Biopsy
- Endoscopy
- Ultrasound
- Urine tests
- Stool tests
- Tumor marker tests
- Genetic testing
Treatment and Medical Assistance
Main goal: Treating the Disease
- Follow-up physical examination
- Follow-up laboratory tests
- Follow-up imaging studies
- Follow-up genetic testing
- Follow-up endoscopy
- Follow-up biopsy
- Follow-up immunotherapy
- Follow-up chemotherapy
- Follow-up radiation therapy
- Follow-up surgery
- Follow-up targeted therapy
- Follow-up immunotherapy
- Follow-up hormone therapy
6 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Follow-up examination after combined treatment for malignant neoplasm - Prevention
In order to prevent a recurrence of malignant neoplasms, it is important to have regular follow-up examinations after combined treatment. this includes a physical examination, imaging tests, and blood tests to monitor for any changes in the tumor. patients should also receive regular counseling to help them manage any side effects of treatment and to ensure they are following healthy lifestyle habits.
Specified forms of the disease
| (O14.0) Mild to moderate pre-eclampsia |
| (O14.1) Severe pre-eclampsia |
| (O14.9) Pre-eclampsia, unspecified |